Michael R. Bristow, See Remarks at ARCA biopharma, Inc. (ABIO), sold 752 shares at $3.50 ($3K) on 2016-03-01, disclosed to the SEC on 2016-03-02.
Scheduled sale ($3k) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ABIO | SELL | 2016-09-21 | $6K | — | Filing → |
| ABIO | SELL | 2016-04-06 | $3K | — | Filing → |
| ABIO | SELL | 2015-09-21 | $11K | — | Filing → |